Dafin Fior Muresanu
Dafin Fior Muresanu
Verified email at umfcluj.ro
TitleCited byYear
Blood-brain barrier alterations in ageing and dementia
BO Popescu, EC Toescu, LM Popescu, O Bajenaru, DF Muresanu, ...
Journal of the neurological sciences 283 (1-2), 99-106, 2009
2122009
A 24‐week, double‐blind, placebo‐controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease
XA Alvarez, R Cacabelos, M Laredo, V Couceiro, C Sampedro, M Varela, ...
European journal of neurology 13 (1), 43-54, 2006
1812006
Mild traumatic brain injury
PE Vos, Y Alekseenko, L Battistin, E Ehler, F Gerstenbrand, DF Muresanu, ...
European journal of neurology 19 (2), 191-198, 2012
1612012
Pleiotropic neuroprotective and metabolic effects of Actovegin's mode of action
F Machicao, DF Muresanu, H Hundsberger, M Pflüger, A Guekht
Journal of the neurological sciences 322 (1-2), 222-227, 2012
992012
Post-stroke dementia–a comprehensive review
MD Mijajlović, A Pavlović, M Brainin, WD Heiss, TJ Quinn, ...
Bmc Medicine 15 (1), 11, 2017
782017
A review of published reports on neuroprotection in spinal cord injury
G Onose, A Anghelescu, DF Muresanu, L Padure, MA Haras, ...
Spinal Cord 47 (10), 716, 2009
762009
Chronic treatment with nanoparticles exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective …
HS Sharma, SF Ali, ZR Tian, SM Hussain, JJ Schlager, PO Sjöquist, ...
Journal of nanoscience and nanotechnology 9 (8), 5073-5090, 2009
762009
Cerebrolysin and Recovery After Stroke (CARS) A randomized, placebo-controlled, double-blind, multicenter trial
DF Muresanu, WD Heiss, V Hoemberg, O Bajenaru, CD Popescu, ...
Stroke 47 (1), 151-159, 2016
722016
Cerebrolysin, a mixture of neurotrophic factors induces marked neuroprotection in spinal cord injury following intoxication of engineered nanoparticles from metals
P Kumaran Menon, D Fior Muresanu, A Sharma, H Mossler, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2012
712012
Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle
A Popa-Wagner, AM Buga, B Popescu, D Muresanu
Journal of neural transmission 122 (1), 47-54, 2015
672015
Neuroregeneration in neurodegenerative disorders
AM Enciu, MI Nicolescu, CG Manole, DF Mureşanu, LM Popescu, ...
BMC neurology 11 (1), 75, 2011
662011
Cocaine-induced breakdown of the blood–brain barrier and neurotoxicity
HS Sharma, D Muresanu, A Sharma, R Patnaik
International review of neurobiology 88, 297-334, 2009
612009
Improved global function and activities of daily living in patients with AD: a placebo-controlled clinical study with the neurotrophic agent Cerebrolysin®
DF Muresanu, M Rainer, H Moessler
Ageing and Dementia Current and Future Concepts, 277-285, 2002
602002
Neuroprotection and neuroplasticity–a holistic approach and future perspectives
DF Muresanu
Journal of the neurological sciences 257 (1-2), 38-43, 2007
592007
A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration
DF Muresanu, XA Alvarez, H Moessler, M Buia, A Stan, D Pintea, ...
Journal of the neurological sciences 267 (1-2), 112-119, 2008
522008
Size-and age-dependent neurotoxicity of engineered metal nanoparticles in rats
A Sharma, DF Muresanu, R Patnaik, HS Sharma
Molecular neurobiology 48 (2), 386-396, 2013
502013
Neurotrophic factors
DF Muresanu
Bucuresti: Libripress 196, 2003
452003
The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease
K Gadhave, N Bolshette, A Ahire, R Pardeshi, K Thakur, C Trandafir, ...
Journal of cellular and molecular medicine 20 (7), 1392-1407, 2016
432016
Neuroprotective effects of cerebrolysin, a combination of different active fragments of neurotrophic factors and peptides on the whole body hyperthermia-induced neurotoxicity …
HS Sharma, A Sharma, H Moessler, DF Muresanu
International review of neurobiology 102, 249-276, 2012
432012
Towards a roadmap in brain protection and recovery
DF Muresanu, A Buzoianu, SI Florian, T von Wild
Journal of cellular and molecular medicine 16 (12), 2861-2871, 2012
412012
The system can't perform the operation now. Try again later.
Articles 1–20